mr. eckhart. thank you for your courage, and i appreciate your wife being here as well. on?e , members of the committee, thank you for the opportunity to appear today. during my career, i have worked with synthetic drugs, assessing schedule one d8 registration. my goal was to understand how the structure of a molecule engaged biological targets, better understanding how the substances interacted with the brain. i am concerned with the harms to human health presented by synthetic drugs. aeir availability for its response, including regulation. yet i do not believe that the proposed legislation would affect spice mixtures. they already -- they focus on already established types. the challenge is to preserve researchers needs well -- while preventing the chemicals. this revolves around three points. first, therapeutic uses. second, legislation should be guided by science. third, the impact on mass incarceration. -- investigators were per will pursue research with schedule one drugs. obtaining a schedule one license is not a trivial matter, and a or must be able to obtain one. i